Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Keytruda“
Suchtreffer
Begriffe & Kennungen
Keytruda · 4.8 · Paediatric population Subcutaneous formulation The safety of pembrolizumab solution for injection for the trea
Eintrag öffnenKeytruda · 4.8 · Paediatric population The safety of pembrolizumab as monotherapy has been evaluated in 161 paediatric patients
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with chemotherapy, radiation therapy (RT) or chemoradiotherapy (CRT) (see section
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with chemotherapy, radiation therapy (RT) or chemoradiotherapy (CRT) (see section
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with enfortumab vedotin (see section 4.2) When pembrolizumab is administered in c
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with enfortumab vedotin (see section 4.2) When pembrolizumab is administered in c
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with tyrosine kinase inhibitor (TKI) (see section 4.2) When pembrolizumab is admi
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with tyrosine kinase inhibitor (TKI) (see section 4.2) When pembrolizumab is admi
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in monotherapy (see section 4.2) The safety of intravenous pembrolizumab as monotherapy has been
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in monotherapy (see section 4.2) The safety of pembrolizumab as monotherapy has been evaluated i
Eintrag öffnenKeytruda · 4.8 · Rare cases of SJS and TEN, some of them with fatal outcome, have been observed (see sections 4.2 and 4.4).
Eintrag öffnenKeytruda · 4.8 · Rare cases of SJS and TEN, some of them with fatal outcome, have been observed (see sections 4.2 and 4.4).
Eintrag öffnenKeytruda · 4.8 · Rare pancreatic exocrine pancreatic exocrine small intestinal insufficiency, small insufficiency, small perfor
Eintrag öffnenKeytruda · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenKeytruda · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenKeytruda · 4.8 · Respiratory, thoracic and mediastinal disorders Very common dyspnoea, cough dyspnoea, cough dyspnoea, cough Co
Eintrag öffnenKeytruda · 4.8 · Subcutaneous formulation The safety profile of KEYTRUDA solution for injection in combination with platinum do
Eintrag öffnenKeytruda · 4.8 · Summary of the safety profile Pembrolizumab is most commonly associated with immune-mediated adverse reactions
Eintrag öffnenKeytruda · 4.8 · Summary of the safety profile Pembrolizumab is most commonly associated with immune-mediated adverse reactions
Eintrag öffnenKeytruda · 4.8 · Table 2: Adverse reactions in patients treated with pembrolizumab†
Eintrag öffnen